Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.65 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.65 |
| ▸ | POLB | P06746 | 5/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | APEX1 | P27695 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
| ▸ | CASP6 | P55212 | 1/20 | 0.39 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1484126 | 1.00 | ALDH1A1 (0.65) | ALDH1A1CYP2C19POLBTDP1APEX1 | |
| SCHEMBL2033299 | 1.00 | ALDH1A1 (0.65) | ALDH1A1CYP2C19POLBTDP1APEX1 | |
| SCHEMBL7232865 | 1.00 | ALDH1A1 (0.65) | ALDH1A1CYP2C19POLBTDP1APEX1 | |
| SCHEMBL311527 | 1.00 | ALDH1A1 (0.65) | ALDH1A1CYP2C19POLBTDP1APEX1 | |
| Hydrochloric Acid SCHEMBL26613189 | 0.98 | ALDH1A1 (0.63) | ALDH1A1CYP2C19POLBTDP1APEX1 | |
| Hydrochloric Acid SCHEMBL26613207 | 0.98 | ALDH1A1 (0.63) | ALDH1A1CYP2C19POLBTDP1APEX1 | |
| Hydrochloric Acid SCHEMBL19668549 | 0.98 | ALDH1A1 (0.63) | ALDH1A1CYP2C19POLBTDP1APEX1 | |
| Hydrochloric Acid SCHEMBL19668550 | 0.98 | ALDH1A1 (0.63) | ALDH1A1CYP2C19POLBTDP1APEX1 | |
| SCHEMBL24062391 | 0.83 | POLB (0.70) | ALDH1A1POLBTDP1APEX1SMN1; SMN2 | |
| SCHEMBL20346210 | 0.83 | POLB (0.70) | ALDH1A1POLBTDP1APEX1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024130161-A2 | NOVEL CAMPTOTHECIN DERIVATIVES AND CONJUGATES THEREOF | BIONECURE THERAPEUTICS INC (US) | 2024-06-20 | — | — | WO | disclosed |
| US-20240034753-A1 | THERAPEUTIC PEPTIDES | COHBAR, INC. | 2024-02-01 | — | — | US | disclosed |
| US-11753445-B2 | Therapeutic peptides | COHBAR, INC. (US) | 2023-09-12 | — | — | US | disclosed |
| US-20230218710-A1 | METHOD OF TREATING CORONAVIRUS INFECTIONS | COHBAR, INC. | 2023-07-13 | — | — | US | disclosed |
| US-20230137562-A1 | TAU AGGREGATION INHIBITORS | ADRX, INC. | 2023-05-04 | — | — | US | disclosed |
| EP-4135738-A2 | METHOD OF TREATING CORONAVIRUS INFECTIONS | Cohbar Inc. (US) | 2023-02-22 | — | — | EP | disclosed |
| US-20220395553-A1 | CXCR4 ANTAGONIST PEPTIDES | COHBAR, INC. | 2022-12-15 | — | — | US | disclosed |
| US-20220332774-A1 | THERAPEUTIC MITOCHONDRIAL PEPTIDES | COHBAR, INC. | 2022-10-20 | — | — | US | disclosed |
| US-20220324909-A1 | THERAPEUTIC PEPTIDES | COHBAR, INC. | 2022-10-13 | — | — | US | disclosed |
| US-20220324925-A1 | THERAPEUTIC PEPTIDES | COHBAR, INC. | 2022-10-13 | — | — | US | disclosed |
| US-20200216495-A1 | TAU AGGREGATION PEPTIDE INHIBITORS | ADRX, INC. | 2020-07-09 | — | — | US | disclosed |
| EP-3668886-A2 | TAU AGGREGATION PEPTIDE INHIBITORS | Adrx, Inc. (US) | 2020-06-24 | — | — | EP | disclosed |
| US-20200181197-A1 | THERAPEUTIC PEPTIDES | COHBAR, INC. | 2020-06-11 | — | — | US | disclosed |
| US-20200062804-A1 | PEPTIDE INHIBITORS OF TRANSCRIPTION FACTOR AGGREGATION | ADRX, INC. | 2020-02-27 | — | — | US | disclosed |
| EP-3519431-A1 | THERAPEUTIC MOTS-C RELATED PEPTIDES | Cohbar Inc. (US) | 2019-08-07 | — | — | EP | disclosed |
| WO-2019036725-A2 | TAU AGGREGATION PEPTIDE INHIBITORS | ADRX, INC. (US) | 2019-02-21 | — | — | WO | disclosed |
| WO-2018156892-A1 | PEPTIDE INHIBITORS OF TRANSCRIPTION FACTOR AGGREGATION | ADRX, INC. (US) | 2018-08-30 | — | — | WO | disclosed |
| WO-2018064098-A1 | THERAPEUTIC MOTS-C RELATED PEPTIDES | COHBAR, INC. (US) | 2018-04-05 | — | — | WO | disclosed |
| US-20150218538-A1 | Methods and Compositions for Modulating G-Alpha-Q Signaling | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-08-06 | — | — | US | disclosed |
| WO-2013165554-A1 | METHODS AND COMPOSITIONS FOR MODULATING G-ALPHA-Q SIGNALING | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2013-11-07 | — | — | WO | disclosed |